Cytori sold 224 consumable units in the quarter 2011, also deadon with our expectations for 225. Between april 6, 2010, and sept 21, 2012, we randomly assigned 329 patients to either the brentuximab vedotin group n165 or the placebo group n164. Safety, tolerability and potential efficacy of injection of autologous adiposederived stromal vascular fraction in the fingers of patients with systemic sclerosis. How might disaggregated cells cause problems of this nature in this study. Mar 16, 2012 safety and feasibility trial of adiposederived regenerative cells in the treatment of chronic myocardial ischemia athena the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Dec 20, 20 the trial, sponsored by san diegobased cytori therapeutics, derives stem cells from the patients own fat tissue and injects extracted cells into damaged parts of the heart. Cytori therapeutics completes patient enrollment in phase 3.
The landmark athena clinical trial explained in infographics. This was deadon with our forecast, and flat sequentially with the second quarter 2011. Florida hospital pepin heart institute is first in west. Cytori therapeutics withholds enrollment in athena trials. Ascendiant downgrades cytori therapeutics as athena trials.
Cytori athena trial for chronic ischemic cardiovascular disease. Effect of dronedarone on cardiovascular events in atrial. Scripps clinic tests stem cell heart therapy the san. Adresu is the worlds first clinical trial for regenerative medicinebased treatment of male stress urinary. Intravenous angiotensin ii for the treatment of highoutput. Cytori therapeutics fourth quarter and fiscal 2015. Yields of melon varieties in the 2017 variety trial in southwest indiana. Nov 19, 20 cytori therapeutics page 2 of 36 yale jen, ph. In terms of developing stromal vascular fraction as a product, cytori began two phase ii u. As previously disclosed in the current report on form 8k filed on march 4, 2015, cytori therapeutics, inc. Cytori therapeutics has placed enrolment in the athena and athena ii trials on clinical hold and therefore anticipates that it will not be possible to complete enrolment of the athena i trial prior to the end of 2014 as previously anticipated. San diego, aug 05, 2014 business wire cytori therapeutics cytx has placed enrollment in the athena and athena ii trials on clinical hold and therefore anticipates that it. A total of 47,208 women aged 21 years or older undergoing routine screening were enrolled.
Emerson perin, md, phd, director, clinical research for cardiovascular medicine and medical director stem cell center, texas heart institute shares an update on the cytori precise trial the. Cytori therapeutics cytx has placed enrollment in the athena and athena ii trials on clinical hold and therefore anticipates that it will not be possible to complete enrollment of the athena i. Cytx ascendiant capital mentioned that the athena trials. At this time, all participants have been placed in a listenonly mode and the floor will be open for your questions following the presentation. The investigators of athena a placebocontrolled, doubleblind, parallel arm trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death. In terms of our enrolling clinical trials in scleroderma, our star trial which is the 80 patient pivotal phase 3 trial is on track to enroll as planned by middle of the year.
Reasons i abandoned my long position in cytori nasdaq. Cytori therapeutics athena trial for chronic ischemic. This reports the 3year endofstudy results comparing the performance of hpv primary screening to different screening and triage combinations. Since cytori technology prepares adrcs exclusively from an adult human patients own adipose. Aug 06, 2014 cytori provides update on athena trial status. Cytx announced today the presentation of six and twelve month data from the athena trials at. The trial, sponsored by san diegobased cytori therapeutics, derives stem cells from the patients own fat tissue and injects extracted cells into damaged parts of the heart. If you would like to ask a question at that time, please press 1 on. Cytori therapeutics cytx ecco50 miss main goal in phase 2.
Athena trial schema bevacizumab is allowed during the chemotherapy phase, but not during maintenance, ie, during treatment in this study. A european trial advance in acute myocardial ischemia ami. Cytx announced today the presentation of six and twelve month data from the athena trials at the annual meeting of the society for cardiovascular angiography and. Cytori therapeutics is a research client of edison investment research limited. Even though, like you said, it only includes up to 45 patients, i think its a. Cytx today announced that the results from the athena trials have been published and are now available online in c cytori athena trial. The phase ii athena trial uses celution to produce a regenerative cell mixture to. Athena a placebocontrolled, doubleblind, parallel arm trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in. Athena trial hold oct14 us fda knee osteoarthritis trial. A study in ovarian cancer patients evaluating rucaparib and nivolumab as maintenance treatment following response to frontline platinumbased chemotherapy athena the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Cytori athena trials on clinical hold cardiovascular news. Patients with distributive shock who require high dose vasopressors have a high mortality. Cytori precise trial update from the american heart. Regeneron, cytori, and endo health are wellpoised to open higher today.
The landmark athena clinical study helped shape our understanding of the role of highrisk hpv testing in cervical cancer screening. Cytx announced today the presentation of six and twelve month data from the athena trials at the annual meeting of the society. Cytori is conducting a phase ii athena study with a second trial athena ii to come in cmi patients. A study in ovarian cancer patients evaluating rucaparib. Cytx announced the topline data as part of the prespecified partial unblinding of 24 week follow up data from the companys actoa trial. Athena is a multicenter, prospective, randomized, doubleblind safety and feasibility trial to investigate the use of cytori cell therapy in patients with heart failure due to ischemic heart disease. Ascendiant capital lowered its buy rating to hold on cytori therapeutics nasdaq. We like this model, as the lipoaspirate would otherwise be disposed. The athena trial seeks to recruit a total of 45 patients to treat for heart failure and coronary artery disease, which can damage the heart by restricting blood flow. In addition, in january 2018, we announced the investigatorinitiated and cytori supported scleradecii clinical trial in france using habeo cell therapy completed its enrollment and six month. Pdf cardiovascular diseases, such as coronary artery disease, aortic. One leading trial using a placebo controlled trial design excluded events related to catheterization or injection procedure in the primary analysis.
In the us, cytori is running a key trial, athena in chronic myocardial ischemia. Cytx today announced that the results from the athena trials have been published and. Clinical trials on eccs50 are currently being conducted to determine if this treatment could improve hand symptoms and function in people with scleroderma. A trial with dronedarone to prevent hospitalization or death. There is a need for understanding the overall mace rate associated with. May 31, 2017 the phase 3 star trial investigating the safety and effectiveness of a cell therapy based on adiposederived regenerative cells adrcs for the treatment of hand dysfunction due to scleroderma has completed the full 48week followup program approved by the u. Cytori looks excellent on the surface including a stunning website. Special situations will reward long term investors fellow investor. Cytori provides update on athena trial status fiercebiotech. The athena trial is a treatment for chronic heart failure due to coronary heart disease. Athena evaluated the cobas hpv test as the primary screen for cervical cancer in women. Cytori therapeutics cytx ide approved by fda for pilot. Special situations will reward long term investors fellow investor, quities have bounced back nicely from the selloff in january that began 2015. Pdf clinical status of tissue engineering and regenerative.
Safety and feasibility trial of adiposederived regenerative cells. Performance of helix transendocardial biotherapeutic delivery. Cytori publishes athena trial data for chronic ischemic cardiovascular disease. Most of the major indices are now at alltime highs as we publish. Rationale and design of the athena hf trial aldosterone targeted neurohormonal combined with natriuresis therapy in heart failure javed butler, md, mph, mba,a adrian f. The proprietary technologies incorporated in cytoris cell therapy and. Cytori athena trial results support symptomatic benefit. Cytx today announced that the results from the athena trials have been published and are now available online in catheterization and cardiovascular interventions, a leading international journal covering the broad field of cardiovascular diseases and the official journal of the society for cardiovascular angiography and. Eccs50 cytori stem cell therapy nihr innovation observatory. Sep 26, 2016 cytori partner kerastem completes enrollment of u. Triaging hpvpositive women with p16ki67 dualstained.
Principal investigator of suspended cytori stem cell trials remains. The trial will enroll up to 45 patients with nooption cmi who have limited therapeutic options. The systemic form, systemic sclerosis, is the focus of the star trial and has a prevalence of 60,000 70,000 patients. Stevenkesten is an employee of cytori therapeutics as chief medical officer. Stevenkesten is an employee of cytori therapeutics as chief medical. Cytx announced today the presentation of six and twelve month data from the athena trials at the annual meeting of the society for. San diego, jun 28, 2016 business wire cytori therapeutics, inc. Performance of helix transendocardial biotherapeutic. All patients had discontinued treatment as of july 25, 20, and the data cutoff for the primary efficacy analysis was aug 18, 2014. I and ii trials, investigating cytori cell use in patients with ischemic.
Safety and feasibility trial of adiposederived regenerative. Clovis oncology announces first patient enrolled in the. Tractor supply co tsco healthy sales growth, cytori. Pharmaceuticals and medical devices agency pmda and successful submission of the clinical trial notification to the ministry of health, labour and welfare mhlw in japan, in collaboration with cytori therapeutics, k. Preclinical and early clinical trials suggest adrcs have excellent potential for ischemic conditions. Cytori athena trial results support symptomatic benefit from cytori cell therapy may 06, 2016 08. The scleradecii which is a 40 patient investigator initiated phase 3 trial, very similar in design to star is also enrolling and continues to enroll in europe. Phase 3 trial of cytoris cell therapy completes 48week. Cytori discuss importance of star trial for scleroderma. In other words, the cytori product empowers clinics to offer a new product at no incremental discomfort to the patient. Technology intended to improve patient care cytori therapeutics. The number and potency of autologous stem cells decline with age and cardiovascular risk factors.
Cytori therapeutics said that its objective of the athena program was the assessment of safety and feasibility of cytori cell therapy with the support of the celution system automated onsite. Weight lb per acre number of fruit per acre average fruit weight lb astound 52,501 az 9,922 a 5. The objective of the study was to describe baseline data from addressing the need for advanced hpv diagnostics, a prospective, multicenter us cervical cancer screening trial. To assess safety and feasibility of autologous adiposederived regenerative cells adrcs, for treatment of chronic ischemic cardiomyopathy patients. We are driven by the pursuit of safe and effective medical devices that improve the health and wellbeing of people. Cytori therapeutics athena trial results support symptomatic benefit from cytori cell therapy. To assess the safety and efficacy of adiposederived regenerative cells adrcs delivered via an intramyocardial route in the treatment of chronic ischemic heart disease in patients who are not eligible for percutaneous or surgical revascularization. Fda decision means a decision by the fda expected to occur on or about october 17, 2014 that results in an outcome pursuant to which the corporation is unable to restart the athena clinical trial without further material changes in the protocol or additional gathering of data resulting in a material delay to the restarting of such. Evaluated effect of highdose spironolactone on outcomes including nterminal prob type natriuretic peptide levels in patients with acute hf. Cytori athena trial for chronic ischemic cardiovascular. Primary cervical cancer screening with human papillomavirus. Cytori provides update on athena trial status marketwatch.
Welcome to the cytori therapeutics fourth quarter and 2015 earnings results call. Cytori halts athena trials over safety concerns wsj. Cytori publishes athena trial data for chronic ischemic. Cytori sold only 7 revenue generating systems in the third quarter, bringing the total installed base to 176 units in approximately 30 countries worldwide. However, there were two likely vascular events in the previous apollo study one. Cytori therapeutics is an emerging cell therapy company focusing on the development of adipose.
Physicians and scientists have demonstrated the frequency of stem cells in adipose fat tissue to be 2,500 times greater than the frequency of similar cells in bone marrow. Cytori therapeutics fourth quarter and fiscal 2015 earnings. There is a need for understanding the overall mace rate associated with different delivery platforms currently in use. Cytx announced the presentation of six and twelve month data from the athena trials at the annual meeting of the society for cardiovascular angiography and. Topline data potentially become available in 2h14 and 2015, respectively. The athena trial is a large cervical cancer screening trial, enrolling 47,208 women 21 years of age or older at 61 clinical sites throughout the united states. Phase iii scleroderma trial read this article along with other careers information, tips and advice on biospace. Scleroderma is a rare disease, affecting nearly 300,000 patients in the us. Positive results would be major catalysts for cytx share value appreciation. Sep 15, 2005 a trial with dronedarone to prevent hospitalization or death in patients with atrial fibrillation athena the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Cytx today announced that the results from the athena trials have been published and are now available online in c cytori athena trial for chronic ischemic. Women were screened using both lbc and hpv dna testing, and all women 25 years of age or older with an abnormal result on either test, as well as a subset of women who were negative on.
Intravenous angiotensin ii for the treatment of highoutput shock athos trial. Both fulfillment of the first series of barda contractual milestones and success of the athena trial are pivotal to cytori s outlook. Phase ii trial for early stage hair loss read this article along with other careers information, tips and advice on biospace. Safety and feasibility trial of adiposederived regenerative cells in the treatment of chronic myocardial ischemia athena the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Athena and athena ii trials for cardiovascular indications as well as the need to raise cash to fund. Information provided by responsible party cytori therapeutics. Barda contract, athena, and other ongoing clinical trials.
The athena i and ii trials, investigating cytori cell use in patients with ischemic heart failure demonstrated feasibility and safety, but resulted in no differences in lvef or volume when. May 06, 2016 san diego, may 06, 2016 business wire cytori therapeutics, inc. May 31, 2016 cytori therapeutics recently announced that its fdaapproved phase 3 star clinical trial evaluating eccs50 has enrolled and treated its 80th patient, reaching 100 percent of its target enrollment. The twin trials are each testing cytoris adiposederived regenerative. Food and drug administration fda has approved an investigational device exemption ide for a pilot clinical trial to.
192 65 1383 543 1212 997 1027 1251 907 204 1402 1442 771 1004 423 1231 913 264 953 1039 1231 1573 398 510 1019 28 493 1205 825 17 726 803 871 265 1180 1266 592